Journal profile · Medicine-Hematology
Blood Science
ISSN 2543-6368 · Wolters Kluwer Health · United States
Blood Science: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.6 (journal website); JCR Q2 (journal website); diamond open access (no APC); no APC; median 124 days to acceptance (26 articles, last 24 months); 54 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Blood Science is published by Wolters Kluwer Health and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation and CAR-T cell therapy research, together about 32.5% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Blood Science (BLS) is an international single blind, peer-reviewed, open access journal that publishes original research, reviews and news in the field of clinical and experimental hematology, covers the topics on molecular biology, physiology, pathophysiology and clinical applications of blood cells or non-cellular blood components. The central goal of this journal is to provide a platform for researchers to present their high impact discoveries, and to be a forum for the discussion on the important issues in the field.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Hematology
Editor-in-chief Tao ChengPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Myeloid Leukemia ResearchMedicine13%
- Hematopoietic Stem Cell TransplantationMedicine11.2%
- CAR-T cell therapy researchMedicine8.2%
- Acute Lymphoblastic Leukemia researchMedicine5.8%
- Immune Cell Function and InteractionImmunology and Microbiology5.4%
- Lymphoma Diagnosis and TreatmentMedicine4%
- Single-cell and spatial transcriptomicsBiochemistry, Genetics and Molecular Biology3.8%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · HEMATOLOGY · rank 31/103
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.6Publisher website ·
- CiteScore 2026-06
- 4.2LetPub ·
- CiteScore (publisher)
- 4.2Publisher website ·
- SJR 2026-06
- 0.83LetPub ·
- SNIP 2026-06
- 0.79LetPub ·
- h-index
- 20OpenAlex ·
- i10-index
- 49OpenAlex ·
- 2-year mean citedness
- 2.06OpenAlex ·
- Self-citation rate
- 2.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 37LetPub ·
Articles by year OpenAlex count · 304 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 36 | 36 | 17 |
| 2025 | 54 | 54 | 94 |
| 2024 | 40 | 40 | 157 |
| 2023 | 28 | 28 | 231 |
| 2022 | 49 | 49 | 390 |
| 2021 | 32 | 32 | 168 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
124 daysMedian, submission to acceptance · P25–P75 92 days – 171 days
- Acceptance to online
- median 64 days (26 articles)
- Submission to online
- median 189 days
- Sample
- 26 articles with submission and acceptance dates (98 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 10 weeksLetPub ·
- Submission to publication (journal-reported)
- about 10 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC-ND | |
| LetPub | No APC | No | — | |
| Publisher website | USD 1,800 / USD 800 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Manuscript length
- ≤ 5,000 words
- Cover letter
- Required
Article types accepted7
- commentComment 1000 No abstract 1 10 NoLength not stated
- consensus & guidelineConsensus & Guideline No requirements 250 No requirements No requirements NoLength not stated
- editorialType Text* Word count Abstract Word count Figures/Tables References Supplement possible Research Article 5000 250 10 50 Yes Review Article 5000 250 10 100 No Co…Length not stated
- letterType Text* Word count Abstract Word count Figures/Tables References Supplement possible Research Article 5000 250 10 50 Yes Review Article 5000 250 10 100 No Co…Length not stated
- protocolType Text* Word count Abstract Word count Figures/Tables References Supplement possible Research Article 5000 250 10 50 Yes Review Article 5000 250 10 100 No Co…Length not stated
- research articleType Text* Word count Abstract Word count Figures/Tables References Supplement possible Research Article 5000 250 10 50 Yes Review Article 5000 250 10 100 No Co…Length not stated
- review articleType Text* Word count Abstract Word count Figures/Tables References Supplement possible Research Article 5000 250 10 50 Yes Review Article 5000 250 10 100 No Co…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Plagiarism
- Authorship Authorship
Blood Science expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believes it represents valid work, and approves it for submission.
Source ↗Publisher website ·- Conflicts of interest Financial Support and Competing Interests
A financial disclosure section is part of the submission process and must be completed by each author at submission. This information is for review by the Editors but will be published if relevant to the content of the accepted manuscript.
Source ↗Publisher website ·- Publication ethics
Retractions follow COPE guidelines. Model summary
BLS abides by Retraction Guidelines of the Committee on Publication Ethics (COPE)
Source ↗Publisher website ·- License & copyright Open Access Authors Retain Copyright
Authors retain their copyright for all articles. Authors grant Wolters Kluwer a license to publish the article and identify itself as the original publisher.
Source ↗Publisher website ·- Open access Open Access
Authors retain copyright; grant Wolters Kluwer a license to publish. Model summary
Every peer-reviewed research article appearing in this journal will be published open access. This means that the article is universally and freely accessible via the internet in perpetuity, in an easily readable format immediately after publication.
Source ↗Publisher website ·- Peer review Peer Review
Single-blind external peer review process. Model summary
Blood Science (BLS) operates a single-blind external peer review process, wherein the authors are unaware of reviewers’ identity and reviewers are aware of authors’ identity. Brief introduction on editorial review process of the journal:
Source ↗Publisher website ·- Plagiarism Plagiarism
As defined by the World Association of Medical Editors (http://www.wame.org/resources/publication-ethics-policies-for-medical-journals):
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- Country or region
- United States
- Language
- English
- ISSN
- 2543-6368
- Latest issue on the website
- Volume 8, Issue 2 (June 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Blood Science
What CAS zone is Blood Science in?
In the 2025 upgraded edition of the CAS Journal Ranking, Blood Science is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Blood Science?
The journal's website gives an impact factor of 3.6; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.2, h-index 20.
How long does peer review take at Blood Science?
Based on the dates recorded on 26 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 124 days (interquartile range 92–171 days); authors report an average review time of about 10 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Blood Science in?
The journal's website gives JCR Q2; by category, HEMATOLOGY Q2 (31/103). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
What are the manuscript requirements of Blood Science?
According to the journal's author guidelines: Manuscript length: ≤ 5,000 words; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Which databases index Blood Science?
According to LetPub and DOAJ records, Blood Science is indexed in ESCI, Scopus and DOAJ.
Is Blood Science open access, and what is the APC?
Blood Science is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .